pharmaceutical-technology.com
69%
192
EMA advises malaria drugs use for trials only; FDA records shortage
The European Medicines Agency (EMA) has urged that two malaria drugs, chloroquine and hydroxychloroquine, being tested as potential Covid-19 treatment, must only be used for clinical trials or national emergency use programmes.